FINLAY-FR2 anti-SARS-CoV-2 Vaccine

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameFINLAY-FR2 anti-SARS-CoV-2 Vaccine
Drug Alias NameSOBERANA 02FINLAY-FR-2
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Genetically engineered subunit vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCuba
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesFinlay Vaccine Institute
China Registration ClassN/A

Develop Information

Active CompaniesFinlay Vaccine Institute
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A